Contract Signals Long-Term Demand for Simulations Plus' Software and Consulting Services

ANTI-HIV Predictive Models Released by Simulations Plus
Extensions to ADMET Predictor(™) Software Enhance Anti-HIV Activity Discovery Capabilities

Simulations Plus Reports First Quarter FY2007 Financial Results
Record First Quarter Sees Pharmaceutical Revenues Jump 314%

Simulations Plus Announces First Quarter Fiscal Year 2007 Earnings Conference Call
Conference Call to be on Tuesday, January 16, at 4:15 PM EST

Simulations Plus Flagship Software To Aid Government Research Projects
U.S. FDA Licenses GastroPlus(™)

Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis
This study assessed daily aspirate samples from an indwelling sinus catheter during high-dose, short-course levofloxacin (750 mg daily x 5 days) treatment...

Simulations Plus Receives Another Large Pharmaceutical Software License Renewal
Large Pharmaceutical Company Renews Global Software Licenses

Simulations Plus Receives Large Multi-Year Pharmaceutical Software License
Hoffmann-LaRoche Renews Multi-year Software Licenses

Pharmacodynamics of cefprozil against Haemophilus influenzae in an in vitro pharmacodynamic model
An in vitro pharmacodynamic model was used to determine the pharmacokinetic-pharmacodynamic (PK-PD) measure and magnitude most strongly related...

Simulations Plus Releases GastroPlus(™) 5.2
Flagship Software Product Improvements Provide Greater Accuracy and Convenience

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder
A population model was developed with the aim to simultaneously describe risperidone and 9-hydroxyrisperidone pharmacokinetics; to obtain estimates for pharmacokinetic parameters and associated...

Simulations Plus Releases ClassPharmer(™) 4.2
Improvements Provide New Capabilities Requested by User Community

Simulations Plus Reports Preliminary FY2006 Financial Results
Annual Revenues Up 23%, Net Earnings Up 158%

Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract
Novel estrogenic therapies are needed that ameliorate menopausal symptoms and have the bone-sparing effects of endogenous estrogens but do not promote breast or...

Simulations Plus Announces Fiscal Year 2006 Earnings Conference Call
Conference Call to be on Thursday, November 9, at 4:15 PM EST

In Silico Prediction of Ionization
The focus of this chapter is computational methods for the prediction of aqueous ionization of organic molecules.

Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections
Tigecycline, a first-in-class expanded glycylcycline antimicrobial agent, has demonstrated efficacy in the treatment of complicated skin and skin structure infections...

Population Pharmacokinetics of (R)-Albuterol Following Inhaled Levalbuterol or Racemic Albuterol via a Hydrofluoroalkane Metered Dose Inhaler in Pediatric and Adult Asthma Patients
Levalbuterol (LEV), the (R)-enantiomer of racemic albuterol (RA), is approved for the treatment or prevention of bronchospasm in patients ≥4 years of age via metered dose inhaler (MDI). A population…